UNC-CA359 is a potent epidermal growth factor receptor (EGFR) inhibitor (IC50 = 18 nM) with antitumor activity, used in the study of chordoma; it serves as a click chemistry reagent containing an alkyne group that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules.